Mostrar el registro sencillo del ítem
dc.contributor.author | Castilla Catalán, Jesús | |
dc.contributor.author | Navascués, Ana | |
dc.contributor.author | Casado, Itziar | |
dc.contributor.author | Pérez-García, Alejandra | |
dc.contributor.author | Aguinaga, Aitziber | |
dc.contributor.author | Ezpeleta, Guillermo | |
dc.contributor.author | Pozo Sanchez, Francisco | |
dc.contributor.author | Ezpeleta, Carmen | |
dc.contributor.author | Martínez-Baz, Iván | |
dc.date.accessioned | 2020-01-30T09:32:54Z | |
dc.date.available | 2020-01-30T09:32:54Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Euro Surveill. 2018 Feb;23(7). | es_ES |
dc.identifier.issn | 1560-7917 | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/8993 | |
dc.description.abstract | The 2017/18 interim estimate of trivalent influenza vaccine effectiveness (VE) was 39% (95% confidence interval: 20-54) in Navarre. Compared with individuals unvaccinated in the current and five previous seasons, VE against influenza B was 41% for current and any prior doses, 67% for current vaccination only, and 22% for any prior doses, and 43%, 51% and 54%, respectively against influenza A(H3N2). This suggests moderate VE despite predominance of lineage mismatched influenza B. | es_ES |
dc.description.sponsorship | This study was supported by the Horizon 2020 program of the European Commission (agreement 634446); by the I-MOVE (Influenza Monitoring Vaccine Effectiveness in Europe) Network funded by the European Centre for Disease Prevention and Control; and by the Carlos III Institute of Health with the European Regional Development Fund (CM15/00119, INT16/00122). | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | European Centre for Disease Prevention and Control (ECDC) | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Case-control study | es_ES |
dc.subject | Influenza | es_ES |
dc.subject | Influenza vaccine | es_ES |
dc.subject | Influenza-like illness | es_ES |
dc.subject | Repeated vaccination | es_ES |
dc.subject | Vaccine effectiveness | es_ES |
dc.subject.mesh | Adolescent | es_ES |
dc.subject.mesh | Adult | es_ES |
dc.subject.mesh | Aged | es_ES |
dc.subject.mesh | Case-Control Studies | es_ES |
dc.subject.mesh | Child | es_ES |
dc.subject.mesh | Child, Preschool | es_ES |
dc.subject.mesh | Female | es_ES |
dc.subject.mesh | Humans | es_ES |
dc.subject.mesh | Influenza A Virus, H3N2 Subtype | es_ES |
dc.subject.mesh | Influenza B virus | es_ES |
dc.subject.mesh | Influenza Vaccines | es_ES |
dc.subject.mesh | Influenza, Human | es_ES |
dc.subject.mesh | Male | es_ES |
dc.subject.mesh | Middle Aged | es_ES |
dc.subject.mesh | Spain | es_ES |
dc.subject.mesh | Vaccination | es_ES |
dc.subject.mesh | Young Adult | es_ES |
dc.subject.mesh | Seasons | es_ES |
dc.subject.mesh | Sentinel Surveillance | es_ES |
dc.title | Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18 | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Atribución 4.0 Internacional | * |
dc.identifier.pubmedID | 29471624 | es_ES |
dc.format.volume | 23 | es_ES |
dc.format.number | 7 | es_ES |
dc.identifier.doi | 10.2807/1560-7917.ES.2018.23.7.18-00057 | es_ES |
dc.contributor.funder | Unión Europea | |
dc.contributor.funder | European Centre for Disease Prevention and Control | |
dc.contributor.funder | Instituto de Salud Carlos III | |
dc.contributor.funder | Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) | |
dc.description.peerreviewed | Sí | es_ES |
dc.identifier.e-issn | 1560-7917 | es_ES |
dc.relation.publisherversion | https://doi.org/10.2807/1560-7917.ES.2018.23.7.18-00057 | es_ES |
dc.identifier.journal | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.relation.projectID | Horizon 2020 program of the European Commission (agreement 634446) | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/CM15/00119 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/INT16/00122 | es_ES |
dc.rights.accessRights | open access | es_ES |